These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27782859)

  • 21. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
    Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
    Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
    Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML
    Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immortalization of Mesenchymal Stromal Cells by TERT Affects Adenosine Metabolism and Impairs their Immunosuppressive Capacity.
    Beckenkamp LR; da Fontoura DMS; Korb VG; de Campos RP; Onzi GR; Iser IC; Bertoni APS; Sévigny J; Lenz G; Wink MR
    Stem Cell Rev Rep; 2020 Aug; 16(4):776-791. PubMed ID: 32556945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular Nucleotide Hydrolysis in Dermal and Limbal Mesenchymal Stem Cells: A Source of Adenosine Production.
    Naasani LIS; Rodrigues C; de Campos RP; Beckenkamp LR; Iser IC; Bertoni APS; Wink MR
    J Cell Biochem; 2017 Aug; 118(8):2430-2442. PubMed ID: 28120532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunosuppressive effects of fetal bone marrow derived mesenchymal stem cells on in vitro proliferation of adult peripheral lymphocyte and expression of immune-related factors].
    Li F; Lyu J; Duan Y; Sun Y; Li D; Wang Y; Hu X; Xiao D
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):891-6. PubMed ID: 25339324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulatory effects of mesenchymal stromal cells-derived exosome.
    Chen W; Huang Y; Han J; Yu L; Li Y; Lu Z; Li H; Liu Z; Shi C; Duan F; Xiao Y
    Immunol Res; 2016 Aug; 64(4):831-40. PubMed ID: 27115513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy.
    Chinnadurai R; Copland IB; Ng S; Garcia M; Prasad M; Arafat D; Gibson G; Kugathasan S; Galipeau J
    Mol Ther; 2015 Jul; 23(7):1248-1261. PubMed ID: 25899824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape.
    Montalbán Del Barrio I; Penski C; Schlahsa L; Stein RG; Diessner J; Wöckel A; Dietl J; Lutz MB; Mittelbronn M; Wischhusen J; Häusler SFM
    J Immunother Cancer; 2016; 4():49. PubMed ID: 27532024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.
    Plessers J; Dekimpe E; Van Woensel M; Roobrouck VD; Bullens DM; Pinxteren J; Verfaillie CM; Van Gool SW
    Stem Cells Transl Med; 2016 Dec; 5(12):1607-1619. PubMed ID: 27465071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO.
    Tipnis S; Viswanathan C; Majumdar AS
    Immunol Cell Biol; 2010; 88(8):795-806. PubMed ID: 20386557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
    Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
    Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes
    Monguió-Tortajada M; Roura S; Gálvez-Montón C; Franquesa M; Bayes-Genis A; Borràs FE
    Front Immunol; 2017; 8():1577. PubMed ID: 29209319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1.
    García-Rocha R; Monroy-García A; Hernández-Montes J; Weiss-Steider B; Gutiérrez-Serrano V; Del Carmen Fuentes-Castañeda M; Ávila-Ibarra LR; Don-López CA; Torres-Pineda DB; de Lourdes Mora-García M
    Cytokine; 2019 Jun; 118():71-79. PubMed ID: 30301599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro.
    Bochev I; Elmadjian G; Kyurkchiev D; Tzvetanov L; Altankova I; Tivchev P; Kyurkchiev S
    Cell Biol Int; 2008 Apr; 32(4):384-93. PubMed ID: 18262807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.
    Trivedi P; Hematti P
    Exp Hematol; 2008 Mar; 36(3):350-9. PubMed ID: 18179856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune regulation by mesenchymal stem cells derived from adult spleen and thymus.
    Krampera M; Sartoris S; Liotta F; Pasini A; Angeli R; Cosmi L; Andreini A; Mosna F; Bonetti B; Rebellato E; Testi MG; Frosali F; Pizzolo G; Tridente G; Maggi E; Romagnani S; Annunziato F
    Stem Cells Dev; 2007 Oct; 16(5):797-810. PubMed ID: 17999601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone Marrow Mesenchymal Stromal Cells from Clinical Scale Culture: In Vitro Evaluation of Their Differentiation, Hematopoietic Support, and Immunosuppressive Capacities.
    Fajardo-Orduña GR; Mayani H; Castro-Manrreza ME; Flores-Figueroa E; Flores-Guzmán P; Arriaga-Pizano L; Piña-Sánchez P; Hernández-Estévez E; Castell-Rodríguez AE; Chávez-Rueda AK; Legorreta-Haquet MV; Santiago-Osorio E; Montesinos JJ
    Stem Cells Dev; 2016 Sep; 25(17):1299-310. PubMed ID: 27462977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
    Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aging of bone marrow- and umbilical cord-derived mesenchymal stromal cells during expansion.
    de Witte SFH; Lambert EE; Merino A; Strini T; Douben HJCW; O'Flynn L; Elliman SJ; de Klein AJEMM; Newsome PN; Baan CC; Hoogduijn MJ
    Cytotherapy; 2017 Jul; 19(7):798-807. PubMed ID: 28462821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.